I agree that this site is using cookies. You can find further informations here.
X
Anolli, M.P.
~ 0  results:
Search for persons X
?
1

Baseline predictors of virological and biochemical response..:

Degasperi, E. ; Anolli, M.P. ; D'Offizi, G....
Digestive and Liver Disease.  56 (2024)  - p. S32-S33 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Virological and clinical outcomes of patients with HDV-rela..:

Anolli, M.P. ; Degasperi, E. ; Jachs, M....
Digestive and Liver Disease.  56 (2024)  - p. S7-S8 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P504 Prevalence of gastrointestinal infections in ulcerativ..:

Anolli, M P ; Liporace, M F ; Noviello, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1001-i1001 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P921 Maintenance of clinical, biochemical and transmural re..:

Piazza O Sed, N ; Maregatti, M C ; Pessarelli, T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1679-i1679 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Burden of Hepatitis D Virus infection in Italy: interim res..:

Caviglia, G.P. ; Colombatto, P. ; Coco, B....
Digestive and Liver Disease.  56 (2024)  - p. S16 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Kinetics of the three HBsAg forms along with HDV-RNA predic..:

D'Anna, S. ; Salpini, R. ; Degasperi, E....
Digestive and Liver Disease.  56 (2024)  - p. S32 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Bulevirtide monotherapy prevents liver decompensation and r..:

Degasperi, E. ; De Silvestri, A. ; Anolli, M.P....
Digestive and Liver Disease.  56 (2024)  - p. S31-S32 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Quantification of plasma HDV RNA in untreated and Bulevirti..:

Anolli, M.P. ; Renteria, S. Uceda ; Degasperi, E....
Digestive and Liver Disease.  56 (2024)  - p. S33 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Improvement of non-invasive fibrosis tests in HDV cirrhotic..:

Degasperi, E. ; Anolli, M.P. ; Renteria, S. Uceda...
Digestive and Liver Disease.  56 (2024)  - p. S34 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Extension of Bulevirtide monotherapy to 72 weeks in HDV pat..:

Anolli, M.P. ; Degasperi, E. ; D'Offizi, G....
Digestive and Liver Disease.  55 (2023)  - p. S7 , 2023
Link: https://doi.org/10.1016/..
 
?
11

RESIST Criteria: A biochemical algorithm to reduce the numb..:

Calvaruso, V. ; Celsa, C. ; Degasperi, E....
Digestive and Liver Disease.  55 (2023)  - p. S38 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Glecaprevir/Pibrentasvir is safe and effective in Italian p..:

Pugliese, N. ; Calvaruso, V. ; Masarone, M....
Digestive and Liver Disease.  55 (2023)  - p. S26 , 2023
Link: https://doi.org/10.1016/..
 
?
13

T.11.6 TREATMENT WITH GLECAPREVIR AND PIBRENTASVIR IS SAFE ..:

Mastrorocco, E. ; De Marco, A. ; Pugliese, N....
Digestive and Liver Disease.  55 (2023)  - p. S185 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Improvement of clinical parameters in HDV patients with adv..:

Degasperi, E. ; Anolli, M.P. ; Renteria, S.C. Uceda...
Digestive and Liver Disease.  55 (2023)  - p. S29 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Controlled attenuation parameter in primary biliary cholang..:

Degasperi, E. ; Anolli, M.P. ; Perbellini, R....
Digestive and Liver Disease.  54 (2022)  - p. S35 , 2022
Link: https://doi.org/10.1016/..
 
1-15